Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVRx, Inc.CVRX · Entity 6920 | CHIEF OPERATING OFFICER | August 13, 2026 | August 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVRx, Inc.
Report date August 13, 2026 · Filed August 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 56,514 |
Reported balance
After 2026-08-13 transaction · row 1
1 source rowRow 1 · 2026-08-13 · Purchase · Acquired 26,223 · Balance 56,514 F1: Reflects the weighted average price of 26,223 shares of common stock of CVRx, Inc. purchased by the reporting person in multiple transactions on August 13, 2026 with purchase prices ranging from $2.87 to $2.96 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the weighted average price of 26,223 shares of common stock of CVRx, Inc. purchased by the reporting person in multiple transactions on August 13, 2026 with purchase prices ranging from $2.87 to $2.96 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
VASCULAR SOLUTIONS INC
Report date February 17, 2017 · Filed February 22, 2017
Section 16 reporting ended · disclosed 2017-02-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-02-17 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2017-02-17 · Disposition to issuer · Disposed 8,680 · Balance 0 F1: In connection with the merger of Issuer and a subsidiary of Teleflex Incorporated (the "Merger") pursuant to an agreement and plan of merger dated December 1, 2016, all shares of Issuer common stock were canceled and automatically converted into the right to receive $56.00 per share in cash, without interest and less any applicable withholding taxes. |
| Common StockSEC Table I · non-derivative | Direct | 8,680 |
Reported balance
Holding disclosure · report date 2017-02-17 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 8,680 |
Filing footnotes · ownership attribution and instrument terms
F1: In connection with the merger of Issuer and a subsidiary of Teleflex Incorporated (the "Merger") pursuant to an agreement and plan of merger dated December 1, 2016, all shares of Issuer common stock were canceled and automatically converted into the right to receive $56.00 per share in cash, without interest and less any applicable withholding taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 13, 2026 Filed Aug 14, 2026 00:18 UTC | CVRx, Inc. CVRX · Entity 6920 | PurchaseCommon Stock | 26,223 | $2.91 | $76,432.18 |
DisclosureSEC source: 0001644355-26-000007 · form4-08142026_120854.xml · nonDerivative · entry 1 Binkowski Brent · CIK 0001644355 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,514 F1 · price: Reflects the weighted average price of 26,223 shares of common stock of CVRx, Inc. purchased by the reporting person in multiple transactions on August 13, 2026 with purchase prices ranging from $2.87 to $2.96 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 12, 2026 Filed Aug 13, 2026 20:26 UTC | CVRx, Inc. CVRX · Entity 6920 | SaleCommon Stock | 1,309 | $2.55 | $3,338.21 |
DisclosureSEC source: 0001644355-26-000005 · form4-08132026_080826.xml · nonDerivative · entry 1 Binkowski Brent · CIK 0001644355 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,291 F1 · kind: The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction. F2 · price: Reflects the weighted average price of 1,309 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on August 12, 2026 with sale prices ranging from $2.55 to $2.564 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 23:00 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 23,000 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001644355-26-000002 · form4-03032026_110346.xml · derivative · entry 2 Binkowski Brent · CIK 0001644355 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2036-02-26 F2 · derivative.exercise_date: Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 23:00 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001644355-26-000002 · form4-03032026_110346.xml · nonDerivative · entry 1 Binkowski Brent · CIK 0001644355 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,600 F1 · shares: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 20:28 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 74,900 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001415889-25-021649 · form4-08132025_080828.xml · derivative · entry 2 Binkowski Brent · CIK 0001644355 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,900 Underlying: Common Stock · 74,900 shares Expires 2035-08-10 F2 · derivative.exercise_date: Stock options that vest 25% on the first annual anniversary of the date of grant and then 1/48th per month thereafter. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 20:28 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantCommon Stock | 16,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-021649 · form4-08132025_080828.xml · nonDerivative · entry 1 Binkowski Brent · CIK 0001644355 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,600 F1 · shares: Restricted stock units that vest 25% on each anniversary of the grant date Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 16:13 UTC | VASCULAR SOLUTIONS INC VASC · Entity 178639 | Disposition to issuerCommon Stock | 8,680 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-008575 · doc1.xml · nonDerivative · entry 2 Binkowski Brent · CIK 0001644355 · Sr. VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: In connection with the merger of Issuer and a subsidiary of Teleflex Incorporated (the "Merger") pursuant to an agreement and plan of merger dated December 1, 2016, all shares of Issuer common stock were canceled and automatically converted into the right to receive $56.00 per share in cash, without interest and less any applicable withholding taxes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.